Location History:
- Acton, MA (US) (2015)
- West Windsor, NJ (US) (2019)
- Lawrenceville, NJ (US) (2021)
- Cambridge, MA (US) (2022)
Company Filing History:
3 out of 3,923 
2 out of 329 
2 out of 1,976 
Years Active: 2015-2022
Title: Innovations and Contributions of Zhu Alexander Cao
Introduction
Zhu Alexander Cao is a prominent inventor based in Acton, MA, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has made remarkable strides in developing innovative treatments for proliferative diseases, particularly cancer.
Latest Patents
Cao's latest patents include groundbreaking pharmaceutical combinations. One notable patent involves a combination comprising a B-Raf inhibitor, a mitogen-activated protein kinase (MEK) inhibitor, and an epidermal growth factor receptor (EGFR) inhibitor. This combination is designed to be used in the treatment of proliferative diseases, such as cancer. Another significant patent focuses on the combined use of anti-PD-1 and anti-M-CSF antibodies for cancer treatment. This pharmaceutical composition allows for the independent or separate administration of the antibodies in therapeutically effective quantities.
Career Highlights
Throughout his career, Zhu Alexander Cao has worked with leading companies in the pharmaceutical industry, including Novartis AG and Array Biopharma Inc. His work has been instrumental in advancing cancer treatment options and improving patient outcomes.
Collaborations
Cao has collaborated with notable professionals in his field, including Giordano Caponigro and Xizhong Huang. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.
Conclusion
Zhu Alexander Cao's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a leading inventor in the industry. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options for patients.